Search results
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 22 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 3 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 6 days agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer Names Andrew Baum Chief Strategy, Innovation Officer
Morningstar· 1 day agoPfizer had hired Andrew Baum as the drugmaker's next chief strategy and innovation officer. Pfizer on Monday said Baum, who has been Citi's head of global ...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via AOL· 6 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks· 7 days agoPfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 5 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 3 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Pfizer Inc. [PFE] Investment Appeal on the Rise – Knox Daily
Knox Daily· 1 day agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...